1. 373OResults of phase II trial of SL-701, a novel immunotherapy targeting IL-13Ra2, EphA2, and survivin, in adults with second-line recurrent glioblastoma (GBM). (23rd October 2018) Authors: Peereboom, D; Nabors, L B; Kumthekar, P; Badruddoja, M; Fink, K; Lieberman, F; Phuphanich, S; Dunbar, E; Walbert, T; Schiff, D; Tran, D D; Ashby, L S; Butowski, N; Iwamoto, F; Lindsay, R; Bullington, J; Schulder, M; Sherman, J; Brooks, C; Reardon, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P01.057 Effects of tumor treating fields on health-related quality of life (HRQoL) in newly diagnosed glioblastoma: An exploratory analysis of the EF-14 randomized phase III trial. (19th September 2018) Authors: Walbert, T; Lavy-Shahaf, G Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OS01.7.A Detection of methylation-based prognostic signatures in liquid biopsy specimens from patients with meningiomas. (5th September 2022) Authors: Herrgott, G; Snyder, J; She, R; Malta, T; Sabedot, T; Lee, I; Pawloski, J; Asmaro, K; Zhang, J; Cannella, C; Nelson, K; Thomas, B; deCarvalho, A; Poisson, L; Chitale, D; Mukherjee, A; Mosella, M; Robin, A; Walbert, T; Rosenblum, M Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P01.02 Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors. (6th September 2019) Authors: Castro, A V; Wells, M; Asmaro, K; Sabedot, T S; Mosella, M S; Malta, T M; Nelson, K; Snyder, J; deCarvalho, A; Mukherjee, A; Chitale, D; Robin, A; Rosenblum, M; Mikkelsen, T; Poisson, L M; Lee, I; Walbert, T; Bhan, A; Kalkanis, S; Rock, J Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OS1.5 Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers. (6th September 2019) Authors: Noushmehr, H; Sabedot, T; Malta, T; Nelson, K; Snyder, J; Wells, M; deCarvalho, A; Mukherjee, A; Chitale, D; Mosella, M; Asmaro, K; Robin, A; Rosenblum, M; Mikkelsen, T; Rock, J; Poisson, L; Walbert, T; Kalkanis, S; Castro, A Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗